Compare Dishman Pharma with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs STERLING BIOTECH - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA STERLING BIOTECH DISHMAN PHARMA/
STERLING BIOTECH
 
P/E (TTM) x 25.1 -0.4 - View Chart
P/BV x 3.3 0.0 23,491.4% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 DISHMAN PHARMA   STERLING BIOTECH
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
STERLING BIOTECH
Dec-13
DISHMAN PHARMA/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs37411 3,565.7%   
Low Rs1293 3,791.2%   
Sales per share (Unadj.) Rs197.826.8 737.9%  
Earnings per share (Unadj.) Rs21.2-15.0 -141.8%  
Cash flow per share (Unadj.) Rs34.7-5.5 -635.6%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs179.954.9 327.8%  
Shares outstanding (eoy) m80.69267.87 30.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.3 490.7%   
Avg P/E ratio x11.9-0.5 -2,553.9%  
P/CF ratio (eoy) x7.2-1.3 -569.7%  
Price / Book Value ratio x1.40.1 1,104.7%  
Dividend payout %9.40-   
Avg Mkt Cap Rs m20,3061,862 1,090.7%   
No. of employees `0000.81.4 61.2%   
Total wages/salary Rs m5,355547 979.3%   
Avg. sales/employee Rs Th19,252.75,303.3 363.0%   
Avg. wages/employee Rs Th6,459.5403.8 1,599.5%   
Avg. net profit/employee Rs Th2,064.1-2,959.0 -69.8%   
INCOME DATA
Net Sales Rs m15,9617,181 222.3%  
Other income Rs m26543 623.0%   
Total revenues Rs m16,2267,223 224.6%   
Gross profit Rs m4,103947 433.3%  
Depreciation Rs m1,0912,543 42.9%   
Interest Rs m9444,377 21.6%   
Profit before tax Rs m2,334-5,931 -39.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624-1,924 -32.4%   
Profit after tax Rs m1,711-4,007 -42.7%  
Gross profit margin %25.713.2 195.0%  
Effective tax rate %26.732.4 82.4%   
Net profit margin %10.7-55.8 -19.2%  
BALANCE SHEET DATA
Current assets Rs m11,01814,335 76.9%   
Current liabilities Rs m9,51749,809 19.1%   
Net working cap to sales %9.4-494.0 -1.9%  
Current ratio x1.20.3 402.3%  
Inventory Days Days110403 27.4%  
Debtors Days Days35171 20.4%  
Net fixed assets Rs m16,30455,432 29.4%   
Share capital Rs m161268 60.2%   
"Free" reserves Rs m12,90713,935 92.6%   
Net worth Rs m14,51614,701 98.7%   
Long term debt Rs m4,1899,478 44.2%   
Total assets Rs m29,80573,988 40.3%  
Interest coverage x3.5-0.4 -977.9%   
Debt to equity ratio x0.30.6 44.8%  
Sales to assets ratio x0.50.1 551.8%   
Return on assets %8.90.5 1,778.7%  
Return on equity %11.8-27.3 -43.3%  
Return on capital %17.5-6.4 -272.8%  
Exports to sales %24.825.9 95.7%   
Imports to sales %3.70.2 2,199.0%   
Exports (fob) Rs m3,9561,860 212.7%   
Imports (cif) Rs m59612 4,887.7%   
Fx inflow Rs m4,9521,860 266.2%   
Fx outflow Rs m69725 2,799.5%   
Net fx Rs m4,2551,835 231.9%   
CASH FLOW
From Operations Rs m2,7861,719 162.1%  
From Investments Rs m-1,529-3,148 48.6%  
From Financial Activity Rs m-9411,426 -66.0%  
Net Cashflow Rs m316-3 -9,305.9%  

Share Holding

Indian Promoters % 61.4 33.9 181.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.0 -  
FIIs % 12.7 9.9 128.3%  
ADR/GDR % 0.0 16.9 -  
Free float % 22.1 39.3 56.2%  
Shareholders   46,261 21,482 215.3%  
Pledged promoter(s) holding % 35.8 55.9 63.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH  TORRENT PHARMA  

Compare DISHMAN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens above 50,000-Mark; Tata Motors & Bajaj Finance Top Gainers(09:30 am)

Asian share markets rose for the third straight session today, tracking gains in US peers. The Nikkei is trading up by 0.7% and the Hang Seng is trading up by 0.1%.

Related Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 5-YR ANALYSIS

COMPARE DISHMAN PHARMA WITH

MARKET STATS